DR. Carlo Michelangelo Valentino, M.D. is a molecular genetic pathology pathology in Ann Arbor, MI with 17 years of experience. The provider is a molecular genetic pathologist is expert in the principles, theory and technologies of molecular biology and molecular genetics. This expertise is used to make or confirm diagnoses of Mendelian genetic disorders, disorders of human development, infectious diseases and malignancies, and to assess the natural history of those disorders. A molecular genetic pathologist provides information about gene structure, function and alteration and applies laboratory techniques for diagnosis, treatment and prognosis for individuals with related disorders. DR. Carlo Michelangelo Valentino, M.D. NPI is 1316195134. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
The provider's business location address is:
1500 EAST MEDICAL CENTER DR
2ND FLOOR UNIVERSITY HOSPITAL RECP PATHOLOGY
ANN ARBOR, MI
ZIP 48109-054
Phone: (800) 862-7284
The NPI 1316195134 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
- Tissue or cell analysis by immunologic technique (HCPCS:88342)
- Special stained specimen slides to examine tissue (HCPCS:88341)
- Pathology examination of tissue using a microscope, moderately low complexity (HCPCS:88304)
- Pathology examination of tissue using a microscope, moderately high complexity (HCPCS:88307)
The enumeration date for this NPI number is 9/4/2008 and was last updated on 9/5/2012.